M E Suzanne Lewis

Title: M E Suzanne Lewis: Innovator in Recombinant Virus Technology

Introduction

M E Suzanne Lewis is a prominent inventor based in Vancouver, Canada. She has made significant contributions to the field of biotechnology, particularly in the development of recombinant viruses for medical applications. Her innovative work focuses on addressing critical health issues such as atherosclerosis and coronary artery disease.

Latest Patents

M E Suzanne Lewis holds a patent for her invention titled "Recombinant viruses and their use for treatment of atherosclerosis and other forms of coronary artery disease and method, reagent, and kit for evaluating susceptibility to same." This patent involves recombinant viruses that comprise a heterologous DNA sequence coding for a lipase involved in lipoprotein metabolism. The invention also concerns the preparation and therapeutic use of these recombinant viruses, especially for the treatment or prevention of dyslipoproteinemia-related pathologies. She has 1 patent to her name.

Career Highlights

Throughout her career, M E Suzanne Lewis has demonstrated a commitment to advancing medical science through her innovative research. Her work has the potential to significantly impact the treatment of cardiovascular diseases, which are among the leading causes of mortality worldwide.

Collaborations

M E Suzanne Lewis has collaborated with notable professionals in her field, including Patrick Benoit and Patrice Denefle. These collaborations have further enriched her research and contributed to the development of her patented technologies.

Conclusion

M E Suzanne Lewis is a trailblazer in the field of recombinant virus technology, with a focus on improving health outcomes for patients suffering from coronary artery diseases. Her innovative contributions continue to pave the way for advancements in medical treatments.